A Unique Gene Expression Signature of 5-fluorouracil

  • Published : 2005.12.30


To understand the response of cancer cells to anticancer drugs at the gene expression level, we examined the gene expression changes in response to five anticancer drugs, 5-fluorouracil, cytarabine, cisplatin, paclitaxel, and cytochalasin D in NCI-H460 human lung cancer cells. Of the five drugs, 5-fluorouracil had the most distinctive gene expression signature. By clustering genes whose expression changed significantly, we identified three clusters with unique gene expression patterns. The first cluster reflected the up-regulation of gene expression by cisplatin, and included genes involved in cell death and DNA repair. The second cluster pointed to a general reduction of gene expression by most of the anticancer drugs tested. A number of genes in this cluster are involved in signal transduction that is important for communication between cells and reception of extracellular signals. The last cluster represented reduced gene expression in response to 5-fluorouracil, the genes involved being implicated in DNA metabolism, the cell cycle, and RNA processing. Since the gene expression signature of 5-fluorouracil was unique, we investigated it in more detail. Significance analysis of microarray data (SAM) identified 808 genes whose expression was significantly altered by 5-fluorouracil. Among the up-regulated genes, those affecting apoptosis were the most noteworthy. The down-regulated genes were mainly associated with transcription-and translation-related processes which are known targets of 5-fluorouracil. These results suggest that the gene expression signature of an anticancer drug is closely related to its physiological action and the response of caner cells.



  1. Longley, D.B., Harkin, D.P. & Johnston, P.G. 5- fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer. 3, 330-338 (2003) https://doi.org/10.1038/nrc1074
  2. Ohno, Y., Spriggs, D., Matsukage, A., Ohno, T. & Kufe, D. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase beta. Cancer Res. 48, 1494-1498 (1988)
  3. Eastman, A. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther. 34, 155-166 (1987) https://doi.org/10.1016/0163-7258(87)90009-X
  4. Horwitz, S.B. Mechanism of action of taxol. Trends. Pharmacol. Sci. 13, 134-136 (1987) https://doi.org/10.1016/0165-6147(92)90048-B
  5. Goddette, D.W. & Frieden, C. Actin polymerization. The mechanism of action of cytochalasin D. J. Biol. Chem. 261, 15974-15980 (1986)
  6. Yang, Y.H. et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids. Res. 30, e15 (2002) https://doi.org/10.1093/nar/30.2.e2
  7. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. 95, 14863-14868 (1998)
  8. Tusher, V.G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA. 98, 5116- 5121 (2001) https://doi.org/10.1073/pnas.091062498
  9. Gene Ontology Consortium. The Gene Ontology (GO) database and informatics resource. Nucleic. Acids Res. 32, D258-261 (2004) https://doi.org/10.1093/nar/gkh036
  10. Tavazoie, S., Hughes, J.D., Campbell, M.J., Cho, R.J. & Church, G.M. Systematic determination of genetic network architecture. Nature Genet. 22, 281-285 (1999) https://doi.org/10.1038/10343
  11. Kim, S.N. et al. Age-dependent changes of gene expression in the Drosophila head. Neurobiol. Aging 26, 1083-1091 (2005) https://doi.org/10.1016/j.neurobiolaging.2004.06.017
  12. Takahashi, T. et al. p53: a frequent target for genetic abnormalities in lung cancer. Science 246, 491-494 (1989) https://doi.org/10.1126/science.2554494
  13. Maecker, H.L., Koumenis, C. & Giaccia, A.J. p53 Promotes Selection for Fas-mediated Apoptotic Resistance. Cancer Res. 60, 4638-4644 (2000)
  14. Muller, M. et al. p53 Activates the CD95 (APO-1/ Fas) Gene in Response to DNA Damage by Anticancer Drugs. J. Exp. Med. 188, 2033-2045 (1998) https://doi.org/10.1084/jem.188.11.2033
  15. Owen-Schaub, L.B. et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15, 3032-3040 (1995) https://doi.org/10.1128/MCB.15.6.3032
  16. Glazer, R.I. & Lloyd, L.S. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture. Mol. Pharmacol. 21, 468-473 (1982)
  17. Kufe, D.W. & Major, P.P. 5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity. J. Biol. Chem. 256, 9802-9805 (1981)
  18. Nita, M.E. et al. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br. J. Cancer 78, 986-992 (1998) https://doi.org/10.1038/bjc.1998.617
  19. Clarke, P.A. et al. Molecular pharmacology of cancer therapy in human colorectal cancer by gene expression profiling. Cancer Res. 63, 6855-6863 (2003)